1. Home
  2. AJG vs BDX Comparison

AJG vs BDX Comparison

Compare AJG & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arthur J. Gallagher & Co.

AJG

Arthur J. Gallagher & Co.

HOLD

Current Price

$213.04

Market Cap

55.2B

Sector

Finance

ML Signal

HOLD

Logo Becton Dickinson and Company

BDX

Becton Dickinson and Company

HOLD

Current Price

$153.90

Market Cap

51.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AJG
BDX
Founded
1927
1897
Country
United States
United States
Employees
706000
N/A
Industry
Specialty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.2B
51.5B
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
AJG
BDX
Price
$213.04
$153.90
Analyst Decision
Buy
Buy
Analyst Count
15
12
Target Price
$275.71
$188.73
AVG Volume (30 Days)
1.9M
2.0M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
1.28%
2.70%
EPS Growth
N/A
N/A
EPS
5.74
1.34
Revenue
$6,159,600,000.00
$21,840,000,000.00
Revenue This Year
$30.69
N/A
Revenue Next Year
$9.22
$2.22
P/E Ratio
$38.16
$116.08
Revenue Growth
N/A
8.24
52 Week Low
$195.00
$152.99
52 Week High
$351.23
$213.08

Technical Indicators

Market Signals
Indicator
AJG
BDX
Relative Strength Index (RSI) 44.79 34.01
Support Level $204.56 $153.75
Resistance Level $231.10 $160.19
Average True Range (ATR) 6.07 3.10
MACD 0.94 0.99
Stochastic Oscillator 42.96 12.70

Price Performance

Historical Comparison
AJG
BDX

About AJG Arthur J. Gallagher & Co.

Founded in 1927 as a one-person agency, Gallagher's primary business is insurance brokerage, with a focus on serving middle-market companies. The company's risk management segment provides third-party claims adjustment to companies that choose to self-insure. Gallagher has about 72,000 employees and generates about a third of its revenue internationally, primarily in Australia, Canada, New Zealand, and the UK.

About BDX Becton Dickinson and Company

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.

Share on Social Networks: